BN.TO (BN.TO)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 6/9, Altman Z 0.5.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of the entity reveal a significant divergence between capital efficiency and profitability, characterized by an ROIC-WACC spread of -4.5%, indicating that current operations are destroying value relative to the cost of equity. While the DuPont components suggest resilience in gross margins at 24.1% and a strong Beneish M-Score of -2.51 pointing toward low earnings manipulation risk, these strengths are undermined by a net margin contraction to 1.7% and accelerating revenue decline of -12.7%. The balance sheet quality is further flagged by an Altman Z-Score of 0.5, which signals distress territory despite the company maintaining a respectable Piotroski F-Score of 6/9 that suggests reasonable financial strength relative to peers.
Valuation metrics present a stark disconnect from underlying operational performance, with the current P/E ratio at 80.9x standing in sharp contrast to a deteriorating growth trajectory and negative capital returns. This premium multiple implies the market is pricing in substantial future recovery or transformation not yet reflected in historical cash flows, creating a scenario where earnings multiples are decoupled from fundamental value drivers like ROIC. Without evidence of margin expansion or revenue stabilization to justify such high valuation levels, the stock appears priced for a growth narrative that current fundamentals do not support.
The convergence of negative capital returns and distressed Z-Score metrics creates a pronounced risk/reward asymmetry where downside protection is limited by solvency concerns while upside remains contingent on unproven turnaround potential. Investors must weigh whether the high F-Score indicates temporary operational hurdles or if the Altman signal presages deeper structural issues that could further compress valuation multiples in subsequent periods.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
ETF Contagion Visualizer
Simulate a price drop in BN.TO to visualize passive redemption contagion across ETFs and collateral stocks.
If BN.TO (BN.TO) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Royal Bank of Canada (RY) as the most exposed collateral stock, sharing 1 ETFs with BN.TO. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
BN.TO Ownership Dynamics
ETFs with Highest BN.TO Exposure
Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
BN.TO Capital Efficiency
How efficiently does BN.TO convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
BN.TO converts -12% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 112% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-4.5%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Compare BN.TO to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.